Canopy Growth Corp

CGC ·Healthcare, Drug Manufacturers - General, Ontario, Canada
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018
Revenue $77.9M
Cost of Revenue $45.0M
Gross Profit $33.0M
Gross Margin 42.3%
Operating Expenses
Research & Development $2.1M
SG&A Expense $103.5M
Operating Income $-119.6M
Operating Margin -153.4%
Interest Expense $784.0K
Pretax Income $-51.5M
Income Tax Expense $-392.0K
Net Income $-51.1M
Net Margin -65.5%
EPS (Basic) $-0.13
EPS (Diluted) $-0.13
Shares Outstanding (Basic)
Shares Outstanding (Diluted)
Dividends Per Share
← Newer Page 2 of 2 Older →